Ragon Institute Clinical Platform
Platform Overview
The Clinical Platform recruits subjects into our specimen collection studies and first-in-human trials. Specimen types include blood, leukapheresis, sputum and saliva samples, swabs, urine, stool and other microbiome collections, and several tissue biopsy types. These samples provide Ragon investigators with valuable information on how the body responds to HIV and other infectious diseases.
If you would like more information about our studies, please contact the clinical team at 857-268-7257 or by email.
Meet the TeamDouglas S. Kwon, MD, PhD
Scientific Director
Daniel Worrall, NP
Clinical Operations Manager
Research We Support
The Clinical Platform supports a large number of projects in which samples have provided invaluable insight into some of the most pressing research questions. These include the discovery of the mechanisms by which elite controllers suppress HIV indefinitely, understanding how the vaginal microbiome can affect the risk of contracting HIV, and studying COVID-19 patient samples from as early as March 2020, which were essential to better understanding COVID-19 and driving forward vaccine development.